Correction to: Inflammation (2018)
The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below:
-
In Results section under “CP-25 Downregulated GRK2 and EP4 Co-expression of Spleen Tissue in AA Rats” section, the citation “(Fig. 3c, d)” should be “(Fig. 3a, b)”.
-
In Results section, the heading "CP-25 Downregulated the Level of cAMP in T Cell of AA Rats" should be "CP-25 Upregulated the Level of cAMP in T Cell of AA Rats", thus, the sentence “whereas CP-25 significantly reduced cAMP levels in T cells to normal levels (Fig. 7).” should read as "whereas CP-25 significantly upregulated cAMP levels in T cells to normal levels (Fig. 7).".
-
In Figure 7 caption, “Fig. 7. CP-25 downregulated T cell cAMP level in AA rats." should read as “Fig. 7. CP-25 upregulated T cell cAMP level in AA rats.”
-
In Conclusion section, the sentence "but also downregulated moderately inflammatory cytokines secreted by T cells during inflammation and cAMP levels in T cells." should read as "but also downregulated moderately inflammatory cytokines secreted by T cells during inflammation and upregulated cAMP levels in T cells.".
The authors apologize for potential issues raised by these mistakes.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s10753-018-0757-z
Rights and permissions
About this article
Cite this article
Wang, Y., Han, Cc., Cui, D. et al. Correction to: Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis. Inflammation 41, 1064 (2018). https://doi.org/10.1007/s10753-018-0770-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-018-0770-2